Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis

PURPOSE: Repository corticotropin injection (RCI) is indicated for a number of autoimmune-mediated diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and dermatomyositis (DM)/polymyositis (PM). To better understand the practice patterns and outcomes of RCI in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho-Mahler, Nancy, Turner, Beni, Eaddy, Michael, Hanke, Mark L, Nelson, Winnie W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039080/
https://www.ncbi.nlm.nih.gov/pubmed/32110122
http://dx.doi.org/10.2147/OARRR.S231667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039080/
https://www.ncbi.nlm.nih.gov/pubmed/32110122
http://dx.doi.org/10.2147/OARRR.S231667

Ejemplares similares